Literature DB >> 24027270

Opiate exposure and withdrawal induces a molecular memory switch in the basolateral amygdala between ERK1/2 and CaMKIIα-dependent signaling substrates.

Danika Lyons1, Xavier de Jaeger, Laura G Rosen, Tasha Ahmad, Nicole M Lauzon, Jordan Zunder, Lique M Coolen, Walter Rushlow, Steven R Laviolette.   

Abstract

Opiate reward memories are powerful triggers for compulsive opiate-seeking behaviors. The basolateral amygdala (BLA) is an important structure for the processing of opiate-related associative memories and is functionally linked to the mesolimbic dopamine (DA) pathway. Transmission through intra-BLA DA D1-like and D2-like receptors independently modulates the formation of opiate reward memories as a function of opiate-exposure state. Thus, in the opiate-naive state, intra-BLA D1 transmission is required for opiate-related memory formation. Once opiate dependence and withdrawal has developed, a functional switch to a DA D2-mediated memory mechanism takes place. However, the downstream molecular signaling events that control this functional switch between intra-BLA DA D1 versus D2 receptor transmission are not currently understood. Using an unbiased place conditioning procedure in rats combined with molecular analyses, we report that opiate reward memory acquisition requires intra-BLA ERK1/2 signaling only in the previously opiate-naive state. However, following chronic opiate exposure and withdrawal, intra-BLA reward memory processing switches to a CaMKIIα-dependent memory substrate. Furthermore, the ability of intra-BLA DA D1 or D2 receptor transmission to modulate the motivational salience of opiates similarly operates through a D1-mediated ERK-dependent mechanism in the opiate-naive state, but switches to a D2-mediated CaMKIIα-dependent mechanism in the dependent/withdrawn state. Protein analysis of BLA tissue revealed a downregulation of ERK1/2 phosphorylation and a dramatic reduction in both total and phosphorylated CaMKIIα signaling, specifically in the opiate-dependent/withdrawn state, demonstrating functional control of ERK1/2-dependent versus CaMKIIα-dependent memory mechanisms within the BLA, controlled by opiate-exposure state.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24027270      PMCID: PMC6705163          DOI: 10.1523/JNEUROSCI.1226-13.2013

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  64 in total

1.  Behavioral activation induced by D(2)-like receptor stimulation during opiate withdrawal.

Authors:  J P Druhan; C L Walters; G Aston-Jones
Journal:  J Pharmacol Exp Ther       Date:  2000-08       Impact factor: 4.030

2.  Close linkage between calcium/calmodulin kinase II alpha/beta and NMDA-2A receptors in the lateral amygdala and significance for retrieval of auditory fear conditioning.

Authors:  T Moriya; Y Kouzu; S Shibata; H Kadotani; K Fukunaga; E Miyamoto; T Yoshioka
Journal:  Eur J Neurosci       Date:  2000-09       Impact factor: 3.386

3.  Alpha-CaMKII-dependent plasticity in the cortex is required for permanent memory.

Authors:  P W Frankland; C O'Brien; M Ohno; A Kirkwood; A J Silva
Journal:  Nature       Date:  2001-05-17       Impact factor: 49.962

4.  Dopamine attenuates prefrontal cortical suppression of sensory inputs to the basolateral amygdala of rats.

Authors:  J A Rosenkranz; A A Grace
Journal:  J Neurosci       Date:  2001-06-01       Impact factor: 6.167

5.  Inhibition of calcium/calmodulin-dependent protein kinase II in rat hippocampus attenuates morphine tolerance and dependence.

Authors:  G H Fan; L Z Wang; H C Qiu; L Ma; G Pei
Journal:  Mol Pharmacol       Date:  1999-07       Impact factor: 4.436

6.  Modulation of Ca2+/calmodulin-dependent protein kinase II activity by acute and chronic morphine administration in rat hippocampus: differential regulation of alpha and beta isoforms.

Authors:  L Lou; T Zhou; P Wang; G Pei
Journal:  Mol Pharmacol       Date:  1999-03       Impact factor: 4.436

7.  Dopamine D1 and NMDA receptors mediate potentiation of basolateral amygdala-evoked firing of nucleus accumbens neurons.

Authors:  S B Floresco; C D Blaha; C R Yang; A G Phillips
Journal:  J Neurosci       Date:  2001-08-15       Impact factor: 6.167

8.  Inhibition of the amygdala and hippocampal calcium/calmodulin-dependent protein kinase II attenuates the dependence and relapse to morphine differently in rats.

Authors:  L Lu; S Zeng; D Liu; X Ceng
Journal:  Neurosci Lett       Date:  2000-09-22       Impact factor: 3.046

9.  Dynamic control of CaMKII translocation and localization in hippocampal neurons by NMDA receptor stimulation.

Authors:  K Shen; T Meyer
Journal:  Science       Date:  1999-04-02       Impact factor: 47.728

10.  D2 dopamine receptors in striatal medium spiny neurons reduce L-type Ca2+ currents and excitability via a novel PLC[beta]1-IP3-calcineurin-signaling cascade.

Authors:  S Hernandez-Lopez; T Tkatch; E Perez-Garci; E Galarraga; J Bargas; H Hamm; D J Surmeier
Journal:  J Neurosci       Date:  2000-12-15       Impact factor: 6.167

View more
  13 in total

1.  Opiate Exposure State Controls a D2-CaMKIIα-Dependent Memory Switch in the Amygdala-Prefrontal Cortical Circuit.

Authors:  Laura G Rosen; Jordan Zunder; Justine Renard; Jennifer Fu; Walter Rushlow; Steven R Laviolette
Journal:  Neuropsychopharmacology       Date:  2015-07-15       Impact factor: 7.853

2.  Expression of the μ, κ, and δ-opioid receptors and tyrosine hydroxylase in MN9D cells.

Authors:  Pengxiang Tian; Weibo Shi; Jie Liu; Jie Wang; Chunling Ma; Qian Qi; Bin Cong; Yingmin Li
Journal:  Int J Clin Exp Pathol       Date:  2015-05-01

3.  Cannabinoid reward and aversion effects in the posterior ventral tegmental area are mediated through dissociable opiate receptor subtypes and separate amygdalar and accumbal dopamine receptor substrates.

Authors:  Tasha Ahmad; Steven R Laviolette
Journal:  Psychopharmacology (Berl)       Date:  2017-07-01       Impact factor: 4.530

4.  Cannabidiol Counteracts the Psychotropic Side-Effects of Δ-9-Tetrahydrocannabinol in the Ventral Hippocampus through Bidirectional Control of ERK1-2 Phosphorylation.

Authors:  Roger Hudson; Justine Renard; Christopher Norris; Walter J Rushlow; Steven R Laviolette
Journal:  J Neurosci       Date:  2019-09-30       Impact factor: 6.167

5.  Fear Memory Recall Potentiates Opiate Reward Sensitivity through Dissociable Dopamine D1 versus D4 Receptor-Dependent Memory Mechanisms in the Prefrontal Cortex.

Authors:  Jing Jing Li; Hanna Szkudlarek; Justine Renard; Roger Hudson; Walter Rushlow; Steven R Laviolette
Journal:  J Neurosci       Date:  2018-04-23       Impact factor: 6.167

6.  Cannabidiol Counteracts Amphetamine-Induced Neuronal and Behavioral Sensitization of the Mesolimbic Dopamine Pathway through a Novel mTOR/p70S6 Kinase Signaling Pathway.

Authors:  Justine Renard; Michael Loureiro; Laura G Rosen; Jordan Zunder; Cleusa de Oliveira; Susanne Schmid; Walter J Rushlow; Steven R Laviolette
Journal:  J Neurosci       Date:  2016-05-04       Impact factor: 6.167

7.  Dorsal hippocampal NMDA receptor blockade impairs extinction of naloxone-precipitated conditioned place aversion in acute morphine-treated rats by suppressing ERK and CREB phosphorylation in the basolateral amygdala.

Authors:  Wei-Sheng Wang; Zhong-Guo Chen; Wen-Tao Liu; Zhi-Qiang Chi; Ling He; Jing-Gen Liu
Journal:  Br J Pharmacol       Date:  2014-07-01       Impact factor: 8.739

Review 8.  Glutamatergic Systems and Memory Mechanisms Underlying Opioid Addiction.

Authors:  Jasper A Heinsbroek; Taco J De Vries; Jamie Peters
Journal:  Cold Spring Harb Perspect Med       Date:  2021-03-01       Impact factor: 6.915

Review 9.  Neuronal extracellular signal-regulated kinase (ERK) activity as marker and mediator of alcohol and opioid dependence.

Authors:  Eva R Zamora-Martinez; Scott Edwards
Journal:  Front Integr Neurosci       Date:  2014-03-11

Review 10.  Molecular and neuronal plasticity mechanisms in the amygdala-prefrontal cortical circuit: implications for opiate addiction memory formation.

Authors:  Laura G Rosen; Ninglei Sun; Walter Rushlow; Steven R Laviolette
Journal:  Front Neurosci       Date:  2015-11-05       Impact factor: 4.677

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.